March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Get some tips on how to use your voice in HIV advocacy. Learn about advisory councils, community advisory boards, IRBs, and more.
Learn about harmful effects of stigma and discrimination and read inspiring stories of HIV+ women overcoming stigma to lead full, healthy lives.